<?xml version="1.0" encoding="UTF-8"?>
<Pathway xmlns="http://pathvisio.org/GPML/2013a" Name="Serotonin receptor 4/6/7 and NR3C signaling" Organism="Homo sapiens">
  <Comment Source="WikiPathways-description">This pathway is courtesy of Ariadne Genomics Pathway Studio.

Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP734 CPTAC Assay Portal]</Comment>
  <Comment Source="WikiPathways-category">Cellular Process</Comment>
  <Graphics BoardWidth="780.0" BoardHeight="941.0"/>
  <DataNode TextLabel="serotonin" GraphId="c7ec0" Type="Metabolite">
    <Graphics Color="00cc00"/>
    </DataNode>
  <DataNode TextLabel="HTR6" GraphId="afb31" Type="GeneProduct">
    <Comment>5-hydroxytryptamine (serotonin) receptor 6</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="HTR7" GraphId="a5cd1" Type="GeneProduct">
    <Comment>5-hydroxytryptamine (serotonin) receptor 7</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="HTR4" GraphId="ff5e5" Type="GeneProduct">
    <Comment>5 hydroxytryptamine (serotonin) receptor 4</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="GNAS" GraphId="bbbcd" Type="GeneProduct">
    <Comment>GNAS (guanine nucleotide binding protein, alpha stimulating)</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="ADCY" GraphId="a6384" Type="GeneProduct">
    <Comment>Adenylate cyclase</Comment>
    <Graphics Color="ff9900"/>
    </DataNode>
  <DataNode TextLabel="Cyclic AMP" GraphId="a1ca6" Type="Metabolite">
    <Graphics Color="00cc00"/>
    </DataNode>
  <DataNode TextLabel="PKA" GraphId="e4b51" Type="GeneProduct">
    <Comment>cAMP-dependent protein kinase, protein kinase A</Comment>
    <Graphics Color="ff9900"/>
    </DataNode>
  <DataNode TextLabel="RAP1A" GraphId="e811f" Type="GeneProduct">
    <Comment>RAS-related protein-1a</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="BRAF" GraphId="a5ca5" Type="GeneProduct">
    <Comment>v-raf murine sarcoma viral oncogene homolog B1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAP2K1" GraphId="d2aef" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAP2K2" GraphId="c06e8" Type="GeneProduct">
    <Comment>mitogen activated protein kinase kinase 2</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAPK1" GraphId="d2925" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="MAPK3" GraphId="cf078" Type="GeneProduct">
    <Comment>mitogen activated protein kinase 3</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="RPS6KA5" GraphId="dcbd8" Type="GeneProduct">
    <Comment>ribosomal protein S6 kinase, polypeptide 5</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="RPS6K" GraphId="e03b1" Type="GeneProduct">
    <Comment>ribosomal protein S6 kinase</Comment>
    <Graphics Color="ff9900"/>
    </DataNode>
  <DataNode TextLabel="MAPKAPK2" GraphId="ea96c" Type="GeneProduct">
    <Comment>MAP kinase-activated protein kinase 2</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="ELK1" GraphId="f9794" Type="GeneProduct">
    <Comment>ELK1, member of ETS oncogene family</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="CREB1" GraphId="d1ca1" Type="GeneProduct">
    <Comment>cAMP response element-binding protein 1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="SRF" GraphId="a64df" Type="GeneProduct">
    <Comment>serum response factor</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="ATF1" GraphId="bc3c8" Type="GeneProduct">
    <Comment>activating transcription factor 1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="ELK4" GraphId="a8006" Type="GeneProduct">
    <Comment>ETS domain-containing protein Elk-4 (SRF accessory protein 1)</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="EGR1" GraphId="af70b" Type="GeneProduct">
    <Comment>early growth response protein</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <DataNode TextLabel="NR3C1" GraphId="e1dd8" Type="GeneProduct">
    <Comment>nuclear receptor, subfamily 3, group C, member 1</Comment>
    <Graphics Color="cc0000"/>
    </DataNode>
  <Interaction GraphId="a4543">
    <Comment>Direct Regulation serotonin --+&gt; HTR4</Comment>
    <Graphics>
      <Point GraphRef="c7ec0"/>
      <Point GraphRef="ff5e5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e03a9">
    <Comment>Binding HTR6 ---- serotonin</Comment>
    <Comment>10781004 Among the 5-HT receptor subtypes identified in the rat, 5-HT(4(a,b)), 5-HT(6) and 5-HT(7(a,b,c)) activate adenylyl cyclase (AC). 
</Comment>
    <BiopaxRef>c16</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="c7ec0"/>
      <Point GraphRef="afb31"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b81d6">
    <Comment>Binding HTR7 ---- serotonin</Comment>
    <Comment>14724213 During development, serotonin (5-HT) influences transcription of hippocampal GR mRNA via the 5-HT7 receptor. 
</Comment>
    <BiopaxRef>f8b</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="c7ec0"/>
      <Point GraphRef="a5cd1"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e6fe0">
    <Comment>Binding GNAS ---- HTR6</Comment>
    <Comment>9651336 Subtypes 5-HT 6 and 5-HT 7 couple to stimulation of adenylyl cyclases through G s and display high affinities for antipsychotic and antidepressant drugs. 
</Comment>
    <BiopaxRef>ea0</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="afb31"/>
      <Point GraphRef="bbbcd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef7ce">
    <Comment>Binding GNAS ---- HTR7</Comment>
    <Comment>9651336 Subtypes 5-HT 6 and 5-HT 7 couple to stimulation of adenylyl cyclases through G s and display high affinities for antipsychotic and antidepressant drugs. 

16189297 The insensitivity of the high-affinity agonist binding of the human 5-HT 7 receptor to the destabilizing effect of guanine nucleotides (Alberts et al., 2001 ; Krobert et al., 2001 ) is another indication the 5-HT 7 receptor and Ga s protein form a tight complex. 
</Comment>
    <BiopaxRef>ea0</BiopaxRef>
    <BiopaxRef>bfc</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="a5cd1"/>
      <Point GraphRef="bbbcd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a2bb3">
    <Comment>Binding GNAS ---- HTR4</Comment>
    <Comment>11752209 Guanosine-5&amp;apos;-O-(3-[35S]thio)triphosphate binding on membranes and cAMP assays in whole cells revealed that only the h5-HT4b isoform coupled to Galphai/o-proteins in addition to its well-documented Galphas coupling. In contrast, the h5-HT4a receptor coupled only to Galphas-proteins, however, was able to trigger an increase in the intracellular calcium concentration ([Ca(2+)]i). 
</Comment>
    <BiopaxRef>ab8</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="ff5e5"/>
      <Point GraphRef="bbbcd"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="af4cf">
    <Comment>Direct Regulation GNAS --+&gt; ADCY</Comment>
    <Comment>10542136 The modified Gsalpha activates adenylate cyclase and leads to a dramatic increase in intracellular cAMP. 

1908778 (Organ: spleen) The endogenous GTP-dependent ADP-ribosylation of Gs alpha stimulated basal adenylyl cyclase activity. 

9057106 Purified type II adenylyl cyclase was stimulated by forskolin and Gs alpha, but not by protein kinase C-alpha. 

8713997 (Tissue: smooth muscle) G alpha(s) and G alpha(i) stimulate and inhibit adenylyl cyclase, respectively and control cAMP formation. 

9316442 PTH activation of PLC was blocked by antiserums to G alpha q-11 and activation of adenylyl cyclase by G alpha s antiserums. 

7985086 (Tissue: thyroid) Activating mutations of protein Gs alpha that stimulates adenylyl cyclase are present in a subset of thyroid adenomas. 

15546818 However, preincubation of Galpha(s) with GTPgammaS followed by addition of Cu(2+) or Zn(2+) did not alter the ability of Galpha(s) to stimulate AC activity. 

</Comment>
    <BiopaxRef>ab5</BiopaxRef>
    <BiopaxRef>fdb</BiopaxRef>
    <BiopaxRef>acf</BiopaxRef>
    <BiopaxRef>d5b</BiopaxRef>
    <BiopaxRef>ef1</BiopaxRef>
    <BiopaxRef>ee4</BiopaxRef>
    <BiopaxRef>d49</BiopaxRef>
    <Graphics>
      <Point GraphRef="bbbcd"/>
      <Point GraphRef="a6384" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f2002">
    <Comment>Mol Synthesis ADCY --+&gt; Cyclic AMP</Comment>
    <BiopaxRef>c2f</BiopaxRef>
    <BiopaxRef>d1b</BiopaxRef>
    <Graphics Color="00cccc">
      <Point GraphRef="a6384"/>
      <Point GraphRef="a1ca6" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="db949">
    <Comment>Regulation Cyclic AMP --+&gt; PKA</Comment>
    <Comment>8382677 Ca,phospholipid-dependent (PKC) and cAMP-dependent (PKA) protein kinases phosphorylate the alpha-subunit of the Na,K-ATPase from duck salt gland with the incorporation of 0.3 and 0.5 mol 32P/mol of alpha-subunit, respectively. 

8393279 The data indicate that AVP mediates its effect through a cAMP-dependent pathway involving PKA activation whose target is the G protein pathway that regulates apical epithelial Na+ channel activity. 

</Comment>
    <BiopaxRef>f6d</BiopaxRef>
    <BiopaxRef>ddb</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="a1ca6"/>
      <Point GraphRef="e4b51" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ef93f">
    <Comment>Prot Modification PKA --+&gt; RAP1A</Comment>
    <Comment>10217295 PKA phosphorylates Rap-1 at Ser 179 and leads to its activation. 
</Comment>
    <BiopaxRef>c25</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="e4b51"/>
      <Point GraphRef="e811f" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ba145">
    <Comment>Direct Regulation RAP1A --+&gt; BRAF</Comment>
    <Comment>9094716 (CellType: neural, CellLineName: PC 12) Rap1, activated by mutation or by the cAMP-dependent protein kinase PKA, is a selective activator of B-Raf and an inhibitor of Raf-1. 

10976102 (CellType: fibroblast, CellLineName: Swiss 3T3) Rap1 then activates B-Raf and thereby MEK and ERK ( 38 , 53-55 ). 

15572664 By recruiting a different set of adapter proteins, TrkA causes an activation of Rap-1 that stimulates B-Raf. 

12855697 (Tissue: lymph, CellType: t cell) Recent studies indicate that Rap1 activates B-Raf by recruiting B-Raf to the membrane. 

11950876 Rap1, a Ras-related G protein, has been reported to activate B-Raf but to inhibit Raf-1 (Vossler et al., 1997 ). 

10854065 (CellType: spermatid) Moreover, in mouse spermatids, i.e., the haploid cytodifferentiating cells, a so far unidentified protein complex formed by endogenous Rap1/B-Raf/14-3-3 theta can be coimmunoprecipitated. 

15064721 Our study further showed that the E1/4 cell-specific B-Raf activity was stimulated by PLC gamma and subsequent Rap1 activation. 

</Comment>
    <BiopaxRef>ecb</BiopaxRef>
    <BiopaxRef>a8d</BiopaxRef>
    <BiopaxRef>e34</BiopaxRef>
    <BiopaxRef>faa</BiopaxRef>
    <BiopaxRef>c58</BiopaxRef>
    <BiopaxRef>a28</BiopaxRef>
    <BiopaxRef>c39</BiopaxRef>
    <Graphics>
      <Point GraphRef="e811f"/>
      <Point GraphRef="a5ca5" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ff89a">
    <Comment>Prot Modification BRAF --+&gt; MAP2K1</Comment>
    <Comment>7731720 However, there has been no evidence for a direct interaction between B-Raf and Mek-1. 

12218141 (CellType: neutrophil) This is consistent with other findings that C5a causes the activation of Raf-1 and B-Raf, which are upstream stimulators of MEK-1 in human neutrophils, with a peak of activation at 5 min, followed by suppressed activation thereafter ( 38 ). 

15153095 In addition, MEK1/2 can be activated by B-Raf, a neuron-enriched isoform of Raf, which is in turn activated by a cAMP-responsive Ras homologue called Rap-1 [ 41 ]. 

12351703 V., Calleja V., Scimeca J.-C., Filloux C., Calothy G. and Van Obberghen E. (1995) Regulation of the MAP kinases cascade in PC12 cells: B-Raf activates MEK-1 (MAP kinase or ERK kinase) and is inhibited by cAMP. 

12167697 Reactions were immunoblotted as indicated. (B) The reactions were identical to those for panel A, except that recombinant WT-MEK1 activated by recombinant B-Raf in vitro was used to phosphorylate the immunoprecipitated ERKs. 

</Comment>
    <BiopaxRef>dda</BiopaxRef>
    <BiopaxRef>db9</BiopaxRef>
    <BiopaxRef>fa9</BiopaxRef>
    <BiopaxRef>ca7</BiopaxRef>
    <BiopaxRef>eb0</BiopaxRef>
    <BiopaxRef>a78</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="a5ca5"/>
      <Point GraphRef="d2aef" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fe480">
    <Comment>Prot Modification BRAF --+&gt; MAP2K2</Comment>
    <Comment>9733801 (CellLineName: COS I) A , quantitative analysis of the interaction of Raf-1 and B-Raf with MEK-1 and MEK-2 in the yeast two-hybrid system. 

12738761 Next, actions of the D2 receptor on c-Raf and B-Raf, which phosphorylate MEK1/2, were examined (Fig. 10 ). 
</Comment>
    <BiopaxRef>f98</BiopaxRef>
    <BiopaxRef>ae2</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="a5ca5"/>
      <Point GraphRef="c06e8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a92bf">
    <Comment>ProtModification PKA --+&gt; CREB1</Comment>
    <Comment>11181532 PKA is known to phosphorylate and increase the transcriptional activity of several closely related transcription factors in the bZIP family, namely cAMP response element binding protein (CREB), cAMP response element modulator (CREM), and activating transcription factor-1 (ATF-1) (reviewed in Ref. 63 ). 

17464208 (CellType: macrophage, CellLineName: RAW264.7) These results indicate that PKA phosphorylates CREB and so induces VEGF gene expression. 

</Comment>
    <BiopaxRef>c3d</BiopaxRef>
    <BiopaxRef>bad</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="cccc00">
      <Point GraphRef="e4b51"/>
      <Point/>
      <Point GraphRef="d1ca1" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dcdd3">
    <Comment>Prot Modification PKA --+&gt; ATF1</Comment>
    <Comment>7713937 In turn, activated protein kinase A phosphorylates a number of transcription factors including cAMP response element binding protein, cAMP response element modulator, and activating transcription factor 1 ( 29 ) which bind to their respective response elements in the nucleus and result in altered patterns of gene transcription. 
</Comment>
    <BiopaxRef>ec4</BiopaxRef>
    <Graphics ConnectorType="Elbow" Color="cccc00">
      <Point GraphRef="e4b51"/>
      <Point GraphRef="bc3c8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eac2f">
    <Comment>Prot Modification MAP2K1 --+&gt; MAPK3</Comment>
    <BiopaxRef>a46</BiopaxRef>
    <BiopaxRef>bf8</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2aef"/>
      <Point GraphRef="cf078" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d4576">
    <Comment>Prot Modification MAP2K1 --+&gt; MAPK1</Comment>
    <BiopaxRef>f8e</BiopaxRef>
    <BiopaxRef>b40</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2aef"/>
      <Point GraphRef="d2925" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f6d11">
    <Comment>Prot Modification MAP2K2 --+&gt; MAPK1</Comment>
    <Comment>12225966 (Tissue: muscle) We have recently reported that inhibition of muscle MAPKK1/2 (MEK1/2) abolishes isoproterenol-stimulated NKCC activity and ERK1/2 phosphorylation ( 31 ). 

12393899 (Tissue: cortex, CellType: neural) To inhibit the ERK1/2 pathway, we applied PD98059, an inhibitor of MKK1 and MKK2 ( 30 ), which are upstream kinases that phosphorylate and activate ERK1/2. 

</Comment>
    <BiopaxRef>d6c</BiopaxRef>
    <BiopaxRef>b31</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="c06e8"/>
      <Point GraphRef="d2925" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a33e6">
    <Comment>Prot Modification MAP2K2 --+&gt; MAPK3</Comment>
    <Comment>12730329 Two upstream dual specificity enzyme kinases MEK1/MEK2 (MAPKKs) phosphorylate threonine and tyrosine residues of ERK1/2 and initiate an ultrasensitive downstream phosphorylation cascade ( 25 ). 

12496361 (Tissue: nerve, CellType: neural) Activated Ras associates with Raf that phosphorylates and activates the mitogen-activated protein (MAP) kinase kinases MEK1 and MEK2, which in turn phosphorylate the MAP kinases ERK1 and ERK2. 

12832465 All together, these results indicated that MEK2 is not essential for cell proliferation and ERK1/ERK2 activation in response to mitogens. 

12584202 Because MEK1/2 phosphorylates and activates p42/p44MAPK, the inhibitor would be expected to inhibit the phosphorylation of p42/p44MAPK and their downstream targets. 

10650934 Cells were pretreated for 30 min with 10 &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; M PD98059, an inhibitor of MEK1 and -2, the MAPK kinases that are responsible for activation of ERK1 and -2. 

11238126 (CellLineName: AML) MEK-1/2 activation correlated with ERK-1/2 activation in 7 of 14 AML cell lines and 2 of 5 CML cell lines. 

9927426 (CellType: fibroblast, CellLineName: PC 12) Both p42 and p44MAPK are activated by dual phosphorylation on a threonine and a tyrosine residue, achieved by the dual-specificity kinase MKK1/2. 

11983682 (Organ: hippocampal, CellType: neural) Hippocampal neurons were treated with UO126, an inhibitor of MEK1 and MEK2, which can activate ERK1 and ERK2. 

</Comment>
    <BiopaxRef>afb</BiopaxRef>
    <BiopaxRef>f4f</BiopaxRef>
    <BiopaxRef>e4b</BiopaxRef>
    <BiopaxRef>a53</BiopaxRef>
    <BiopaxRef>d7a</BiopaxRef>
    <BiopaxRef>e44</BiopaxRef>
    <BiopaxRef>b9a</BiopaxRef>
    <BiopaxRef>bbe</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="c06e8"/>
      <Point GraphRef="cf078" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee66d">
    <Comment>Prot Modification MAPK1 --+&gt; MAPKAPK2</Comment>
    <Comment>14688255 This co-expression system was used previously in our laboratory to activate GST-RSK CTD ( 21 ), and ERK2 has been reported to activate MK2 ( 26 ). 

8995385 (CellType: leukocyte) First, LY294002, which inhibited Erk-1 and 2 but not p38, failed to inhibit MAPKAPK-2. 

8900202 (CellLineName: Pam 212) MBP is an efficient substrate for ERK1 and ERK2, whereas GST-cJun (1-169) includes the activating phosphorylation sites Ser-63 and Ser-73, which have been shown to be phosphorylated by SAPK/JNK but not by ERK1, ERK2, or p38 HOG1 ( 3 ). 2 Similarly, hsp27 is an efficient substrate for MAPKAPK2, which in turn is predominantly activated by p38 HOG1, although MAPKAPK2 can also be phosphorylated in vitro by ERK1 and ERK2 ( 29 , 30 ). -- Fig. 2. 

14499342 (CellType: neutrophil) ERK phosphorylated MK2 in vitro and activated MK2 in f-methionyl-leucyl-phenylalanine (FMLP)-stimulated neutrophils. 

8846784 (CellLineName: KB) In contrast, full-length GST-MAPKAP kinase-2 was phosphorylated at Thr25 (and not activated) by p42 MAPK, suggesting a role for the N-terminal domain in specifying activation by RK in vivo. 

10625698 (Organ: ventricle, CellType: myocyte) Activated MAPK interacts with a number of downstream targets, including the p90 ribosomal S6 kinase (p90 Rsk ) ( 19 ) and MAPK-activated protein kinase-2 (MAPKAP-K2 ) ( 20 , 21 ), which are activated by ERK1/2 and p38 MAPK , respectively. 

11463795 (Tissue: skeletal muscle, CellType: adipocyte) With respect to alternative non-PLD/PA mechanisms whereby ERK could conceivably activate PKC-eta/ , it has been reported that ERK-activated MAPK-activated kinase-2 ( 34 , 35 ) and MSK-1 ( 36 ) can act like PDK-1 and/or PDK-2 and phosphorylate PKB on serine 308 and threonine 473 residues. 

</Comment>
    <BiopaxRef>ebb</BiopaxRef>
    <BiopaxRef>e67</BiopaxRef>
    <BiopaxRef>c51</BiopaxRef>
    <BiopaxRef>e01</BiopaxRef>
    <BiopaxRef>cf5</BiopaxRef>
    <BiopaxRef>d17</BiopaxRef>
    <BiopaxRef>cb5</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2925"/>
      <Point GraphRef="ea96c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4f29">
    <Comment>Prot Modification MAPK1 --+&gt; RPS6KA5</Comment>
    <Comment>11701463 Suppression of ERK and p38 MAPK is required to suppress the activation of MSK1. 

12628924 The nuclear kinase MSK1 is activated by both ERK and p38 MAPK. 
</Comment>
    <BiopaxRef>bcf</BiopaxRef>
    <BiopaxRef>b12</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2925"/>
      <Point GraphRef="dcbd8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="efc22">
    <Comment>Prot Modification MAPK1 --+&gt; ELK1</Comment>
    <Comment>10463587 MAP kinase (MAPK/ERK) phosphorylates Elk-1, which is part of the ternary complex factor that binds to the serum response element in the fos promotor; JNK phosphorylates c-Jun, Elk-1, and ATF-2; and p38 kinase phosphorylates both ternary-complex-factor /Elk-1 and ATF-2. 

11520792 (CellType: monocyte) TCFs, such as Elk-1, Sap-1, and Fli-1, are targets of the MAPK pathway. 36 , 37 Our data indicated that phosphorylation of Elk-1 by the MEK-ERK1/2 pathway induces Egr-1 expression in LPS-stimulated monocytes and subsequent TF gene expression. 

11812784 (Organ: renal, Tissue: stroma, CellType: b cell, CellLineName: JEG3) Activated ERK1/2 phosphorylated Elk-1, which involves in the induction of the growth-related genes, suggesting that stimulative effects of low-dose irradiation were mediated by ERK1/2 activation. 

11090049 (Organ: umbilical vein, Tissue: smooth muscle, CellType: fibroblast) Therefore, it has been proposed that Elk1-dependent gene activation can occur independently of SRE/SRF if it can bind to the promoter efficiently. 50 This proposition is supported by the finding that the phosphorylation of Elk1 by ERK2 increases its ability to bind to DNA without interacting with SRF 54 , 55 and by the fact that Elk1 binding is facilitated in transfection experiments with a reporter gene containing multiple high-affinity Elk1 binding sites 40 , 56 or phosphorylation in its C-terminus. 55 , 57 Even though the 9E3/cCAF promoter does not contain an SRE, Elk1 binds to the Elk1 elements and activates transcription, suggesting that thrombin-induced Elk1 activation does not require cooperation with SRF. 

</Comment>
    <BiopaxRef>b10</BiopaxRef>
    <BiopaxRef>fc4</BiopaxRef>
    <BiopaxRef>b38</BiopaxRef>
    <BiopaxRef>dd8</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2925"/>
      <Point GraphRef="f9794" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="d0ddb">
    <Comment>Prot Modification MAPK1 --+&gt; RPS6K</Comment>
    <BiopaxRef>d61</BiopaxRef>
    <BiopaxRef>ed6</BiopaxRef>
    <BiopaxRef>d25</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="d2925"/>
      <Point GraphRef="e03b1" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bd491">
    <Comment>Prot Modification MAPK3 --+&gt; RPS6K</Comment>
    <Comment>12562867 Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. 

11895866 (CellLineName: A431) Silibinin inhibits constitutive activation of MAPK/ERK1/2 in A431 cells. 

9395450 ERK1/2 has been shown to phosphorylate and activate pp90 rsk , leading to phosphorylation of S6 protein and increased protein synthesis. 

14715266 (Tissue: marrow, CellType: osteoblast, CellLineName: CFU-O) H(2)O(2) treatment stimulated phospholipase C-gamma1 (PLC-gamma1), extracellular signal-regulated kinase 1/2 (ERK1/2), and NF-kappaB signaling but inhibited p38 mitogen-activated protein kinase (MAPK) activation. 

9039124 (Organ: umbilical vein, Tissue: smooth muscle, CellLineName: RASMCs) To further confirm the specificity of these results implicating the MAPK pathway, an antisense oligodeoxynucleotide (ODN) directed against the initiation translation site of rat ERK-1 and ERK-2 mRNA was used to suppress MAP kinase synthesis and function in rat VSMCs. 

</Comment>
    <BiopaxRef>e54</BiopaxRef>
    <BiopaxRef>dc9</BiopaxRef>
    <BiopaxRef>e9a</BiopaxRef>
    <BiopaxRef>e73</BiopaxRef>
    <BiopaxRef>d83</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="cf078"/>
      <Point GraphRef="e03b1" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b6119">
    <Comment>Prot Modification MAPK3 --+&gt; RPS6KA5</Comment>
    <Comment>12414794 ATF1 can be phosphorylated by mitogen- and stress-activated protein kinase 1 (MSK1), which is activated by EGF and ERK1/2. 
</Comment>
    <BiopaxRef>ca5</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="cf078"/>
      <Point GraphRef="dcbd8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="f5c9e">
    <Comment>Prot Modification MAPK3 --+&gt; MAPKAPK2</Comment>
    <Comment>7592979 In this article we use a recombinant glutathione S -transferase (GST)-MAPKAP kinase 2-fusion protein and various mutants to study the mechanism of activation of MAPKAP kinase 2 by p44 (ERK1) and p38/40 (RK) in vitro . 

10753939 The ERK1 and ERK2 activator, MEK1 , has also been observed to activate MAPKAPK2 ( 58 ). 
</Comment>
    <BiopaxRef>caa</BiopaxRef>
    <BiopaxRef>a91</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="cf078"/>
      <Point GraphRef="ea96c" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="c657e">
    <Comment>Prot Modification MAPK3 --+&gt; ELK4</Comment>
    <Comment>9130707 Sap-1a is phosphorylated by ERK-1. 
</Comment>
    <BiopaxRef>da0</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="cf078"/>
      <Point GraphRef="a8006" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e9ff8">
    <Comment>Prot Modification MAPK3 --+&gt; ELK1</Comment>
    <Comment>11463794 (CellLineName: COS-7) A, phosphorylation of Elk1 by HA-ERK1 and HA-ERK1b. 

12498787 Since Erk1 and Erk2 regulate transcription from the Fos serum response element (SRE) by phosphorylating the ternary complex factors Elk-1 and SAP-1 ( Treisman, 1995 ), we examined the effect of integrin ligation on the Fos SRE. 

12032150 (Organ: kidney, CellLineName: Madin Darby) In the nucleus, activated ERK1/2 continuously phosphorylate Elk-1, leading to the prolonged expression of c- fos , which results in the expression of several genes such as matrix metalloproteinase (mmp)-9 ; MMP-9 activity is required for the induction of the cell motility response. 

11297525 (Tissue: marrow) In addition, the activation of ERK1/2 correlated with increased activation of the downstream transcription factor Elk-1. 

11782488 (Tissue: cortex, CellType: neural, CellLineName: PC 12) It was also reported that BMK1 activation is required for neurotrophin stimulation of MEF2C in both cortical neurons and PC12 cells, distinct from ERK1/2-induced activation of Elk1 and CREB transcription factors ( 30 ). 

11751459 (Tissue: lymph, CellLineName: reh) On bryo 1 treatment, the activity of ERK2 (p42) rapidly increased, with ERK1 (p44) protein levels remaining constant. p44/42 immunoprecipitates from lysates of bryo 1-treated cells had increased their ability to phosphorylate the transcription factor Elk-1. 

10024371 (Organ: liver, Tissue: fat, CellType: eosinophil, CellLineName: CWSV1) Induction of the SRE occurs upon formation of a ternary complex with serum response factor, p62 TCF , and the SRE. 118 ERK1/2 was shown to phosphorylate p62 TCF (also known as elk-1 or SAP-1), resulting in enhanced ternary complex formation. 119 Thus, the SRE present in the c- fos promoter may be regulated by angiotensin II??????stimulated ERK1/2 phosphorylation of p62 TCF , as shown for EGF. 119 Activation of ERK1/2 requires activation of Ras and Raf, events that are regulated by tyrosine phosphorylation. 

</Comment>
    <BiopaxRef>a7e</BiopaxRef>
    <BiopaxRef>a00</BiopaxRef>
    <BiopaxRef>d41</BiopaxRef>
    <BiopaxRef>d23</BiopaxRef>
    <BiopaxRef>b8e</BiopaxRef>
    <BiopaxRef>bef</BiopaxRef>
    <BiopaxRef>d32</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="cf078"/>
      <Point GraphRef="f9794" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="bf7f1">
    <Comment>Binding ELK4 ---- SRF</Comment>
    <BiopaxRef>aa8</BiopaxRef>
    <BiopaxRef>f34</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="a8006"/>
      <Point GraphRef="a64df"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="b1244">
    <Comment>Binding ELK1 ---- SRF</Comment>
    <Comment>11053438 (Tissue: serum) Activation of Transcription Factor Elk1 during Thapsigargin-induced pip92 Expression-- Previous studies have shown that serum response element (SRE ) present in the pip92 promoter can interact with recombinant serum response factor (SRF ) and Elk1 proteins forming a tertiary complex ( 16 , 25 ). 

11839761 (Tissue: serum) When phosphorylated by ERK2, Elk-1 forms a complex with the serum response factor and binds the serum response promoter element to enhance transcription from the c- fos promoter. 

10477597 Also, they phosphorylate Elk1, which interacts with the serum response factor and participates in c- fos activation (reviewed in Refs. 18 and 19 ). 

12600988 First, it has been concluded from many transfection (permanent and transient) experiments that the serum response factor-ELK1 complex, likely also including the nearby AP-1 proteins, is required for the optimal transcriptional response to growth factors and to phorbol esters (TPA ). 

11245588 The three MAP kinase pathways regulate AP-1 activity both by increasing the transcription of the jun and fos genes and by phosphorylation of newly synthesized AP-1 transcription complexes. c-Fos gene transcription is activated by the cooperative interaction of Elk-1 with the serum response factor (SRF). 

</Comment>
    <BiopaxRef>ecd</BiopaxRef>
    <BiopaxRef>cbf</BiopaxRef>
    <BiopaxRef>e43</BiopaxRef>
    <BiopaxRef>ac0</BiopaxRef>
    <BiopaxRef>e11</BiopaxRef>
    <Graphics Color="cc00cc">
      <Point GraphRef="a64df"/>
      <Point GraphRef="f9794"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eb6a3">
    <Comment>Prot Modification RPS6K --+&gt; CREB1</Comment>
    <Comment>10098484 However, the MEK inhibitor PD98059 was not able to modulate phosphorylation of CREB at a dose that fully inhibited the phosphorylation of MAP kinase (Fig. 6b ). 

10951185 (CellType: dendritic) This could occur via RSK2, a protein kinase activated by MAP kinases/ERKs, that phosphorylates CREB on its activator site serine 133 [ 43 ]. 

</Comment>
    <BiopaxRef>cfa</BiopaxRef>
    <BiopaxRef>d6b</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="e03b1"/>
      <Point GraphRef="d1ca1" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="dfbe4">
    <Comment>Prot Modification RPS6KA5 --+&gt; ATF1</Comment>
    <BiopaxRef>ca5</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="dcbd8"/>
      <Point GraphRef="bc3c8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="e944a">
    <Comment>Prot Modification MAPKAPK2 --+&gt; SRF</Comment>
    <Comment>10318869 MAPKAP Kinase 2 Phosphorylates Serum Response Factor in Vitro and in Vivo * Olaf Heidenreich , Armin Neininger &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; ** , Gerhard Schratt , Raymund Zinck &#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189; || , Michael A. 

12808055 MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo. 
</Comment>
    <BiopaxRef>d63</BiopaxRef>
    <BiopaxRef>de0</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="ea96c"/>
      <Point GraphRef="a64df" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="cb92f">
    <Comment>Prot Modification MAPKAPK2 --+&gt; CREB1</Comment>
    <Comment>11278709 PKA , PKC , CaM kinase, CK2 , MAPKAP kinase-2, p60 S6K , and p90 RSK have been reported to phosphorylate CREB . 

11006268 It has been reported that MAPKAP kinase-2 phosphorylates CREB in response to fibroblast growth factor in neuroblastoma cells ( 45 ). 

11123233 (CellLineName: P0) Furthermore, activation of MAPKAP kinase 2 results in activation of the transcriptional factor CREB ( 44 ) as well as HSP27 in human cells and HSP25 in bovine and murine cells ( 4 , 17 ). 

9139689 (CellType: pre B) One of the downstream targets of p38 is the MAPKAP kinase-2, which can activate the transcription factors CREB and ATF-1 ( 18 ) and phosphorylate heat-shock protein hsp27 ( 19 , 20 ). 

9422727 (CellLineName: 9L) Although it has been shown that MAPKAPK-2 phosphorylates CREB at Ser-133 in vitro ( 73 ), we did not observe an increase in phosphorylation of CREB by MAPKAPK-2 activated by OA HS. 

10487749 MK2 phosphorylates the nuclear transcription factors CREB (Tan et al. , 1996 ; Iordanov et al. , 1997 ), ATF-1 (Tan et al. , 1996 ) and SRF (Heidenreich et al. , 1999 ), indicating a role in transcriptional regulation. 

8887554 (CellLineName: sk-n-mc) We show that MAPKAP kinase-2 phosphorylates CREB at Ser133 in vitro, that the FGF- or stress-induced activation of MAPKAP kinase-2 and phosphorylation of CREB and ATF-1 are prevented by similar concentrations of the specific p38 MAP kinase inhibitor SB 203580, and that MAPKAP kinase-2 is the only detectable SB 203580-sensitive CREB kinase in SK-N-MC cell extracts. 

</Comment>
    <BiopaxRef>f0c</BiopaxRef>
    <BiopaxRef>bd4</BiopaxRef>
    <BiopaxRef>a22</BiopaxRef>
    <BiopaxRef>b5e</BiopaxRef>
    <BiopaxRef>daa</BiopaxRef>
    <BiopaxRef>e56</BiopaxRef>
    <BiopaxRef>a1d</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="ea96c"/>
      <Point GraphRef="d1ca1" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="ee9dc">
    <Comment>Prot Modification MAPKAPK2 --+&gt; ATF1</Comment>
    <Comment>10487749 MK2 phosphorylates the nuclear transcription factors CREB (Tan et al. , 1996 ; Iordanov et al. , 1997 ), ATF-1 (Tan et al. , 1996 ) and SRF (Heidenreich et al. , 1999 ), indicating a role in transcriptional regulation. 
</Comment>
    <BiopaxRef>e56</BiopaxRef>
    <Graphics Color="cccc00">
      <Point GraphRef="ea96c"/>
      <Point GraphRef="bc3c8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="a4989">
    <Comment>Promoter Binding CREB1 --+&gt; EGR1</Comment>
    <Comment>11818496 To examine the effect of GnRH on CREB binding to the Egr-1 promoter CRE, a T3 cell were treated with or without GnRH. 

7608156 We demonstrated previously that CREB constitutively binds the CRE in the egr-1 promoter (12). 
</Comment>
    <BiopaxRef>ec7</BiopaxRef>
    <BiopaxRef>db1</BiopaxRef>
    <Graphics Color="00cc00">
      <Point GraphRef="d1ca1"/>
      <Point GraphRef="af70b" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="eaa1b">
    <Comment>Promoter Binding SRF --+&gt; EGR1</Comment>
    <Comment>12554779 Our data provide the first evidence that SRF is expressed in granulosa cells and binds the Egr-1 promoter. 


16903857 (Organ: hippocampal) However, SRF binding to egr1 promoter sites was constitutive. 
</Comment>
    <BiopaxRef>f28</BiopaxRef>
    <BiopaxRef>c1c</BiopaxRef>
    <Graphics Color="00cc00">
      <Point GraphRef="a64df"/>
      <Point GraphRef="af70b" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="af4bb">
    <Comment>Regulation ATF1 --+&gt; EGR1</Comment>
    <Comment>10391889 (CellLineName: 293) We have shown that the phosphorylation of CREB and ATF1 after p38/SAPK2 activation allows their binding to the egr-1 promoter and causes a transient induction of egr-1 . 
</Comment>
    <BiopaxRef>e2c</BiopaxRef>
    <Graphics LineStyle="Broken">
      <Point GraphRef="bc3c8"/>
      <Point GraphRef="af70b" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <Interaction GraphId="fb34b">
    <Comment>PromoterBinding EGR1 --+&gt; NR3C1</Comment>
    <Comment>16303171 Differences in the DNA methylation pattern between the offspring of High and Low licking/grooming-arched-back mothers emerge over the first week of life, are reversed with cross-fostering, persist into adulthood and are associated with altered histone acetylation and transcription factor (NGFI-A) binding to the glucocorticoid receptor promoter. 

15220929 These differences emerged over the first week of life, were reversed with cross-fostering, persisted into adulthood and were associated with altered histone acetylation and transcription factor (NGFI-A) binding to the GR promoter. 
</Comment>
    <BiopaxRef>e7c</BiopaxRef>
    <BiopaxRef>d6e</BiopaxRef>
    <Graphics Color="00cc00">
      <Point GraphRef="af70b"/>
      <Point GraphRef="e1dd8" ArrowHead="mim-necessary-stimulation"/>
    </Graphics>
    </Interaction>
  <InfoBox/>
  <Biopax>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db1">
      <bp:ID >7608156</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transcriptional activation of egr-1 by granulocyte-macrophage colony-stimulating factor but not interleukin 3 requires phosphorylation of cAMP response element-binding protein (CREB) on serine 133.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Lee HJ</bp:AUTHORS>
      <bp:AUTHORS >Mignacca RC</bp:AUTHORS>
      <bp:AUTHORS >Sakamoto KM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ebb">
      <bp:ID >14688255</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Chrestensen CA</bp:AUTHORS>
      <bp:AUTHORS >Schroeder MJ</bp:AUTHORS>
      <bp:AUTHORS >Shabanowitz J</bp:AUTHORS>
      <bp:AUTHORS >Hunt DF</bp:AUTHORS>
      <bp:AUTHORS >Pelo JW</bp:AUTHORS>
      <bp:AUTHORS >Worthington MT</bp:AUTHORS>
      <bp:AUTHORS >Sturgill TW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a53">
      <bp:ID >12584202</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Bakovic M</bp:AUTHORS>
      <bp:AUTHORS >Waite K</bp:AUTHORS>
      <bp:AUTHORS >Vance DE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a7e">
      <bp:ID >11463794</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Yung Y</bp:AUTHORS>
      <bp:AUTHORS >Yao Z</bp:AUTHORS>
      <bp:AUTHORS >Aebersold DM</bp:AUTHORS>
      <bp:AUTHORS >Hanoch T</bp:AUTHORS>
      <bp:AUTHORS >Seger R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e67">
      <bp:ID >8995385</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Chemotactic peptide N-formyl-met-leu-phe activation of p38 mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase-2 in human neutrophils.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Krump E</bp:AUTHORS>
      <bp:AUTHORS >Sanghera JS</bp:AUTHORS>
      <bp:AUTHORS >Pelech SL</bp:AUTHORS>
      <bp:AUTHORS >Furuya W</bp:AUTHORS>
      <bp:AUTHORS >Grinstein S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dc9">
      <bp:ID >11895866</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.</bp:TITLE>
      <bp:SOURCE >Carcinogenesis</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Singh RP</bp:AUTHORS>
      <bp:AUTHORS >Tyagi AK</bp:AUTHORS>
      <bp:AUTHORS >Zhao J</bp:AUTHORS>
      <bp:AUTHORS >Agarwal R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ee4">
      <bp:ID >7985086</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >An in vitro model of thyroid neoplasia: permanently transfected FRTL-5 cells with thyroglobulin promoter-cholera toxin A1 subunit minigene.</bp:TITLE>
      <bp:SOURCE >Surgery</bp:SOURCE>
      <bp:YEAR >1994</bp:YEAR>
      <bp:AUTHORS >Saji M</bp:AUTHORS>
      <bp:AUTHORS >Levine MA</bp:AUTHORS>
      <bp:AUTHORS >Zeiger MA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e54">
      <bp:ID >12562867</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >pp90RSK- and protein kinase C-dependent pathway regulates p42/44MAPK-induced LDL receptor transcription in HepG2 cells.</bp:TITLE>
      <bp:SOURCE >J Lipid Res</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Kapoor GS</bp:AUTHORS>
      <bp:AUTHORS >Golden C</bp:AUTHORS>
      <bp:AUTHORS >Atkins B</bp:AUTHORS>
      <bp:AUTHORS >Mehta KD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a00">
      <bp:ID >12498787</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphorylation of hippocampal Erk-1/2, Elk-1, and p90-Rsk-1 during contextual fear conditioning: interactions between Erk-1/2 and Elk-1.</bp:TITLE>
      <bp:SOURCE >Mol Cell Neurosci</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Sananbenesi F</bp:AUTHORS>
      <bp:AUTHORS >Fischer A</bp:AUTHORS>
      <bp:AUTHORS >Schrick C</bp:AUTHORS>
      <bp:AUTHORS >Spiess J</bp:AUTHORS>
      <bp:AUTHORS >Radulovic J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="daa">
      <bp:ID >9422727</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:ID >9422727</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Chen KD</bp:AUTHORS>
      <bp:AUTHORS >Chen LY</bp:AUTHORS>
      <bp:AUTHORS >Huang HL</bp:AUTHORS>
      <bp:AUTHORS >Lieu CH</bp:AUTHORS>
      <bp:AUTHORS >Chang YN</bp:AUTHORS>
      <bp:AUTHORS >Chang MD</bp:AUTHORS>
      <bp:AUTHORS >Lai YK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dd8">
      <bp:ID >11090049</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Novel nuclear target for thrombin: activation of the Elk1 transcription factor leads to chemokine gene expression.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Li QJ</bp:AUTHORS>
      <bp:AUTHORS >Vaingankar S</bp:AUTHORS>
      <bp:AUTHORS >Sladek FM</bp:AUTHORS>
      <bp:AUTHORS >Martins-Green M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b40">
      <bp:ID >15805288</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Venkatasubbarao K</bp:AUTHORS>
      <bp:AUTHORS >Choudary A</bp:AUTHORS>
      <bp:AUTHORS >Freeman JW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a78">
      <bp:ID >9361191</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Inducible expression of a mutant form of MEK1 in Swiss 3T3 cells.</bp:TITLE>
      <bp:SOURCE >J Cell Biochem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Syu LJ</bp:AUTHORS>
      <bp:AUTHORS >Guan KL</bp:AUTHORS>
      <bp:AUTHORS >Saltiel AR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d41">
      <bp:ID >12032150</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Prolonged nuclear retention of activated extracellular signal-regulated kinase 1/2 is required for hepatocyte growth factor-induced cell motility.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Tanimura S</bp:AUTHORS>
      <bp:AUTHORS >Nomura K</bp:AUTHORS>
      <bp:AUTHORS >Ozaki K</bp:AUTHORS>
      <bp:AUTHORS >Tsujimoto M</bp:AUTHORS>
      <bp:AUTHORS >Kondo T</bp:AUTHORS>
      <bp:AUTHORS >Kohno M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d61">
      <bp:ID >11606615</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Open-system approaches to gene expression in the CNS.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Sutcliffe JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >serotonin signaling pathway</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >PW:0000854</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Pathway Ontology</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6e">
      <bp:ID >15220929</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Epigenetic programming by maternal behavior.</bp:TITLE>
      <bp:SOURCE >Nat Neurosci</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Weaver IC</bp:AUTHORS>
      <bp:AUTHORS >Cervoni N</bp:AUTHORS>
      <bp:AUTHORS >Champagne FA</bp:AUTHORS>
      <bp:AUTHORS >D'Alessio AC</bp:AUTHORS>
      <bp:AUTHORS >Sharma S</bp:AUTHORS>
      <bp:AUTHORS >Seckl JR</bp:AUTHORS>
      <bp:AUTHORS >Dymov S</bp:AUTHORS>
      <bp:AUTHORS >Szyf M</bp:AUTHORS>
      <bp:AUTHORS >Meaney MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a91">
      <bp:ID >10753939</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Arachidonic acid activates mitogen-activated protein (MAP) kinase-activated protein kinase 2 and mediates adhesion of a human breast carcinoma cell line to collagen type IV through a p38 MAP kinase-dependent pathway.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Paine E</bp:AUTHORS>
      <bp:AUTHORS >Palmantier R</bp:AUTHORS>
      <bp:AUTHORS >Akiyama SK</bp:AUTHORS>
      <bp:AUTHORS >Olden K</bp:AUTHORS>
      <bp:AUTHORS >Roberts JD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e11">
      <bp:ID >11245588</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidant stress and endothelial cell dysfunction.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Lum H</bp:AUTHORS>
      <bp:AUTHORS >Roebuck KA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecb">
      <bp:ID >9094716</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway.</bp:TITLE>
      <bp:SOURCE >Cell</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Vossler MR</bp:AUTHORS>
      <bp:AUTHORS >Yao H</bp:AUTHORS>
      <bp:AUTHORS >York RD</bp:AUTHORS>
      <bp:AUTHORS >Pan MG</bp:AUTHORS>
      <bp:AUTHORS >Rim CS</bp:AUTHORS>
      <bp:AUTHORS >Stork PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d32">
      <bp:ID >10024371</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Neural encoding in orbitofrontal cortex and basolateral amygdala during olfactory discrimination learning.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Schoenbaum G</bp:AUTHORS>
      <bp:AUTHORS >Chiba AA</bp:AUTHORS>
      <bp:AUTHORS >Gallagher M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c58">
      <bp:ID >11950876</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases.</bp:TITLE>
      <bp:SOURCE >J Cell Sci</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hindley A</bp:AUTHORS>
      <bp:AUTHORS >Kolch W</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e56">
      <bp:ID >10487749</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Winzen R</bp:AUTHORS>
      <bp:AUTHORS >Kracht M</bp:AUTHORS>
      <bp:AUTHORS >Ritter B</bp:AUTHORS>
      <bp:AUTHORS >Wilhelm A</bp:AUTHORS>
      <bp:AUTHORS >Chen CY</bp:AUTHORS>
      <bp:AUTHORS >Shyu AB</bp:AUTHORS>
      <bp:AUTHORS >M&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;ller M</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
      <bp:AUTHORS >Resch K</bp:AUTHORS>
      <bp:AUTHORS >Holtmann H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b9a">
      <bp:ID >9927426</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Brunet A</bp:AUTHORS>
      <bp:AUTHORS >Roux D</bp:AUTHORS>
      <bp:AUTHORS >Lenormand P</bp:AUTHORS>
      <bp:AUTHORS >Dowd S</bp:AUTHORS>
      <bp:AUTHORS >Keyse S</bp:AUTHORS>
      <bp:AUTHORS >Pouyss&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;gur J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b8e">
      <bp:ID >11782488</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Suzaki Y</bp:AUTHORS>
      <bp:AUTHORS >Yoshizumi M</bp:AUTHORS>
      <bp:AUTHORS >Kagami S</bp:AUTHORS>
      <bp:AUTHORS >Koyama AH</bp:AUTHORS>
      <bp:AUTHORS >Taketani Y</bp:AUTHORS>
      <bp:AUTHORS >Houchi H</bp:AUTHORS>
      <bp:AUTHORS >Tsuchiya K</bp:AUTHORS>
      <bp:AUTHORS >Takeda E</bp:AUTHORS>
      <bp:AUTHORS >Tamaki T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a1d">
      <bp:ID >8887554</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Tan Y</bp:AUTHORS>
      <bp:AUTHORS >Rouse J</bp:AUTHORS>
      <bp:AUTHORS >Zhang A</bp:AUTHORS>
      <bp:AUTHORS >Cariati S</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
      <bp:AUTHORS >Comb MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b10">
      <bp:ID >10463587</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells.</bp:TITLE>
      <bp:SOURCE >Cancer Res</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Vasilevskaya IA</bp:AUTHORS>
      <bp:AUTHORS >O'Dwyer PJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c3d">
      <bp:ID >11181532</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dmrt1 expression is regulated by follicle-stimulating hormone and phorbol esters in postnatal Sertoli cells.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Chen JK</bp:AUTHORS>
      <bp:AUTHORS >Heckert LL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c39">
      <bp:ID >15064721</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transformation potency of ErbB heterodimer signaling is determined by B-Raf kinase.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Hatakeyama M</bp:AUTHORS>
      <bp:AUTHORS >Yumoto N</bp:AUTHORS>
      <bp:AUTHORS >Yu X</bp:AUTHORS>
      <bp:AUTHORS >Shirouzu M</bp:AUTHORS>
      <bp:AUTHORS >Yokoyama S</bp:AUTHORS>
      <bp:AUTHORS >Konagaya A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a28">
      <bp:ID >10854065</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A novel rap1/B-Raf/14-3-3 theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells.</bp:TITLE>
      <bp:SOURCE >Exp Cell Res</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Berruti G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ddb">
      <bp:ID >8393279</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Vasopressin and protein kinase A activate G protein-sensitive epithelial Na+ channels.</bp:TITLE>
      <bp:SOURCE >Am J Physiol</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Prat AG</bp:AUTHORS>
      <bp:AUTHORS >Ausiello DA</bp:AUTHORS>
      <bp:AUTHORS >Cantiello HF</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f4f">
      <bp:ID >12496361</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Extracellular signal-regulated protein kinase signaling is uncoupled from initial differentiation of central nervous system stem cells to neurons.</bp:TITLE>
      <bp:SOURCE >Mol Cancer Res</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Enarsson M</bp:AUTHORS>
      <bp:AUTHORS >Erlandsson A</bp:AUTHORS>
      <bp:AUTHORS >Larsson H</bp:AUTHORS>
      <bp:AUTHORS >Forsberg-Nilsson K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ecd">
      <bp:ID >11053438</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Intracellular calcium mobilization induces immediate early gene pip92 via Src and mitogen-activated protein kinase in immortalized hippocampal cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Chung KC</bp:AUTHORS>
      <bp:AUTHORS >Sung JY</bp:AUTHORS>
      <bp:AUTHORS >Ahn W</bp:AUTHORS>
      <bp:AUTHORS >Rhim H</bp:AUTHORS>
      <bp:AUTHORS >Oh TH</bp:AUTHORS>
      <bp:AUTHORS >Lee MG</bp:AUTHORS>
      <bp:AUTHORS >Ahn YS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fdb">
      <bp:ID >1908778</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Evidence for the endogenous GTP-dependent ADP-ribosylation of the alpha-subunit of the stimulatory guanyl-nucleotide-binding protein concomitant with an increase in basal adenylyl cyclase activity in chicken spleen cell membrane.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Obara S</bp:AUTHORS>
      <bp:AUTHORS >Yamada K</bp:AUTHORS>
      <bp:AUTHORS >Yoshimura Y</bp:AUTHORS>
      <bp:AUTHORS >Shimoyama M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cfa">
      <bp:ID >10098484</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Corticotropin-releasing factor type 1 and type 2alpha receptors regulate phosphorylation of calcium/cyclic adenosine 3',5'-monophosphate response element-binding protein and activation of p42/p44 mitogen-activated protein kinase.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Rossant CJ</bp:AUTHORS>
      <bp:AUTHORS >Pinnock RD</bp:AUTHORS>
      <bp:AUTHORS >Hughes J</bp:AUTHORS>
      <bp:AUTHORS >Hall MD</bp:AUTHORS>
      <bp:AUTHORS >McNulty S</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cb5">
      <bp:ID >11463795</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Glucose activates protein kinase C-zeta /lambda through proline-rich tyrosine kinase-2, extracellular signal-regulated kinase, and phospholipase D: a novel mechanism for activating glucose transporter translocation.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Bandyopadhyay G</bp:AUTHORS>
      <bp:AUTHORS >Sajan MP</bp:AUTHORS>
      <bp:AUTHORS >Kanoh Y</bp:AUTHORS>
      <bp:AUTHORS >Standaert ML</bp:AUTHORS>
      <bp:AUTHORS >Quon MJ</bp:AUTHORS>
      <bp:AUTHORS >Reed BC</bp:AUTHORS>
      <bp:AUTHORS >Dikic I</bp:AUTHORS>
      <bp:AUTHORS >Farese RV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ea0">
      <bp:ID >9651336</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Stimulation of type 1 and type 8 Ca2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Baker LP</bp:AUTHORS>
      <bp:AUTHORS >Nielsen MD</bp:AUTHORS>
      <bp:AUTHORS >Impey S</bp:AUTHORS>
      <bp:AUTHORS >Metcalf MA</bp:AUTHORS>
      <bp:AUTHORS >Poser SW</bp:AUTHORS>
      <bp:AUTHORS >Chan G</bp:AUTHORS>
      <bp:AUTHORS >Obrietan K</bp:AUTHORS>
      <bp:AUTHORS >Hamblin MW</bp:AUTHORS>
      <bp:AUTHORS >Storm DR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec4">
      <bp:ID >7713937</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of rDNA transcription factors during cardiomyocyte hypertrophy induced by adrenergic agents.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Hannan RD</bp:AUTHORS>
      <bp:AUTHORS >Luyken J</bp:AUTHORS>
      <bp:AUTHORS >Rothblum LI</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8e">
      <bp:ID >9891015</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitogen-activated protein kinase.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Ravanti L</bp:AUTHORS>
      <bp:AUTHORS >Heino J</bp:AUTHORS>
      <bp:AUTHORS >L&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;pez-Ot&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;n C</bp:AUTHORS>
      <bp:AUTHORS >K&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;h&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;ri VM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c51">
      <bp:ID >8900202</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1996</bp:YEAR>
      <bp:AUTHORS >Tao J</bp:AUTHORS>
      <bp:AUTHORS >Sanghera JS</bp:AUTHORS>
      <bp:AUTHORS >Pelech SL</bp:AUTHORS>
      <bp:AUTHORS >Wong G</bp:AUTHORS>
      <bp:AUTHORS >Levy JG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a46">
      <bp:ID >15657416</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Sanna B</bp:AUTHORS>
      <bp:AUTHORS >Bueno OF</bp:AUTHORS>
      <bp:AUTHORS >Dai YS</bp:AUTHORS>
      <bp:AUTHORS >Wilkins BJ</bp:AUTHORS>
      <bp:AUTHORS >Molkentin JD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ec7">
      <bp:ID >11818496</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >GnRH regulates early growth response protein 1 transcription through multiple promoter elements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Duan WR</bp:AUTHORS>
      <bp:AUTHORS >Ito M</bp:AUTHORS>
      <bp:AUTHORS >Park Y</bp:AUTHORS>
      <bp:AUTHORS >Maizels ET</bp:AUTHORS>
      <bp:AUTHORS >Hunzicker-Dunn M</bp:AUTHORS>
      <bp:AUTHORS >Jameson JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e34">
      <bp:ID >15572664</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of p90 Rsk1 is sufficient for differentiation of PC12 cells.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Silverman E</bp:AUTHORS>
      <bp:AUTHORS >Fr&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;din M</bp:AUTHORS>
      <bp:AUTHORS >Gammeltoft S</bp:AUTHORS>
      <bp:AUTHORS >Maller JL</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="eb0">
      <bp:ID >12167697</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Eblen ST</bp:AUTHORS>
      <bp:AUTHORS >Slack JK</bp:AUTHORS>
      <bp:AUTHORS >Weber MJ</bp:AUTHORS>
      <bp:AUTHORS >Catling AD</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bad">
      <bp:ID >17464208</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The PKA/CREB pathway is closely involved in VEGF expression in mouse macrophages.</bp:TITLE>
      <bp:SOURCE >Mol Cells</bp:SOURCE>
      <bp:YEAR >2007</bp:YEAR>
      <bp:AUTHORS >Jeon SH</bp:AUTHORS>
      <bp:AUTHORS >Chae BC</bp:AUTHORS>
      <bp:AUTHORS >Kim HA</bp:AUTHORS>
      <bp:AUTHORS >Seo GY</bp:AUTHORS>
      <bp:AUTHORS >Seo DW</bp:AUTHORS>
      <bp:AUTHORS >Chun GT</bp:AUTHORS>
      <bp:AUTHORS >Yie SW</bp:AUTHORS>
      <bp:AUTHORS >Eom SH</bp:AUTHORS>
      <bp:AUTHORS >Kim PH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f6d">
      <bp:ID >8382677</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Phosphorylation of the Na,K-ATPase by Ca,phospholipid-dependent and cAMP-dependent protein kinases. Mapping of the region phosphorylated by Ca,phospholipid-dependent protein kinase.</bp:TITLE>
      <bp:SOURCE >J Bioenerg Biomembr</bp:SOURCE>
      <bp:YEAR >1993</bp:YEAR>
      <bp:AUTHORS >Chibalin AV</bp:AUTHORS>
      <bp:AUTHORS >Lopina OD</bp:AUTHORS>
      <bp:AUTHORS >Petukhov SP</bp:AUTHORS>
      <bp:AUTHORS >Vasilets LA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bbe">
      <bp:ID >11983682</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Induction of neuronal differentiation by a peptide corresponding to the homophilic binding site of the second Ig module of the neural cell adhesion molecule.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Soroka V</bp:AUTHORS>
      <bp:AUTHORS >Kiryushko D</bp:AUTHORS>
      <bp:AUTHORS >Novitskaya V</bp:AUTHORS>
      <bp:AUTHORS >Ronn LC</bp:AUTHORS>
      <bp:AUTHORS >Poulsen FM</bp:AUTHORS>
      <bp:AUTHORS >Holm A</bp:AUTHORS>
      <bp:AUTHORS >Bock E</bp:AUTHORS>
      <bp:AUTHORS >Berezin V</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e01">
      <bp:ID >14499342</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils.</bp:TITLE>
      <bp:SOURCE >Cell Signal</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Coxon PY</bp:AUTHORS>
      <bp:AUTHORS >Rane MJ</bp:AUTHORS>
      <bp:AUTHORS >Uriarte S</bp:AUTHORS>
      <bp:AUTHORS >Powell DW</bp:AUTHORS>
      <bp:AUTHORS >Singh S</bp:AUTHORS>
      <bp:AUTHORS >Butt W</bp:AUTHORS>
      <bp:AUTHORS >Chen Q</bp:AUTHORS>
      <bp:AUTHORS >McLeish KR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a8d">
      <bp:ID >10976102</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Barberis L</bp:AUTHORS>
      <bp:AUTHORS >Wary KK</bp:AUTHORS>
      <bp:AUTHORS >Fiucci G</bp:AUTHORS>
      <bp:AUTHORS >Liu F</bp:AUTHORS>
      <bp:AUTHORS >Hirsch E</bp:AUTHORS>
      <bp:AUTHORS >Brancaccio M</bp:AUTHORS>
      <bp:AUTHORS >Altruda F</bp:AUTHORS>
      <bp:AUTHORS >Tarone G</bp:AUTHORS>
      <bp:AUTHORS >Giancotti FG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d49">
      <bp:ID >15546818</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Copper and zinc inhibit Galphas function: a nucleotide-free state of Galphas induced by Cu2+ and Zn2+.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Gao X</bp:AUTHORS>
      <bp:AUTHORS >Du Z</bp:AUTHORS>
      <bp:AUTHORS >Patel TB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e73">
      <bp:ID >14715266</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-kappaB.</bp:TITLE>
      <bp:SOURCE >Biochem Biophys Res Commun</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Bai XC</bp:AUTHORS>
      <bp:AUTHORS >Lu D</bp:AUTHORS>
      <bp:AUTHORS >Bai J</bp:AUTHORS>
      <bp:AUTHORS >Zheng H</bp:AUTHORS>
      <bp:AUTHORS >Ke ZY</bp:AUTHORS>
      <bp:AUTHORS >Li XM</bp:AUTHORS>
      <bp:AUTHORS >Luo SQ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="afb">
      <bp:ID >12730329</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lysophosphatidic acid signals through mitogen-activated protein kinase-extracellular signal regulated kinase in ovarian theca cells expressing the LPA1/edg2-receptor: involvement of a nonclassical pathway?</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Budnik LT</bp:AUTHORS>
      <bp:AUTHORS >Brunswig-Spickenheier B</bp:AUTHORS>
      <bp:AUTHORS >Mukhopadhyay AK</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ed6">
      <bp:ID >11487632</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cyclin-dependent kinase 4 and cyclin D1 are required for excitotoxin-induced neuronal cell death in vivo.</bp:TITLE>
      <bp:SOURCE >J Neurosci</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Ino H</bp:AUTHORS>
      <bp:AUTHORS >Chiba T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c1c">
      <bp:ID >16903857</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Long-term depression activates transcription of immediate early transcription factor genes: involvement of serum response factor/Elk-1.</bp:TITLE>
      <bp:SOURCE >Eur J Neurosci</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Lindecke A</bp:AUTHORS>
      <bp:AUTHORS >Korte M</bp:AUTHORS>
      <bp:AUTHORS >Zagrebelsky M</bp:AUTHORS>
      <bp:AUTHORS >Horejschi V</bp:AUTHORS>
      <bp:AUTHORS >Elvers M</bp:AUTHORS>
      <bp:AUTHORS >Widera D</bp:AUTHORS>
      <bp:AUTHORS >Pr&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;llage M</bp:AUTHORS>
      <bp:AUTHORS >Pfeiffer J</bp:AUTHORS>
      <bp:AUTHORS >Kaltschmidt B</bp:AUTHORS>
      <bp:AUTHORS >Kaltschmidt C</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d23">
      <bp:ID >11297525</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Barry OP</bp:AUTHORS>
      <bp:AUTHORS >Mullan B</bp:AUTHORS>
      <bp:AUTHORS >Sheehan D</bp:AUTHORS>
      <bp:AUTHORS >Kazanietz MG</bp:AUTHORS>
      <bp:AUTHORS >Shanahan F</bp:AUTHORS>
      <bp:AUTHORS >Collins JK</bp:AUTHORS>
      <bp:AUTHORS >O'Sullivan GC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab8">
      <bp:ID >11752209</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Pindon A</bp:AUTHORS>
      <bp:AUTHORS >van Hecke G</bp:AUTHORS>
      <bp:AUTHORS >van Gompel P</bp:AUTHORS>
      <bp:AUTHORS >Lesage AS</bp:AUTHORS>
      <bp:AUTHORS >Leysen JE</bp:AUTHORS>
      <bp:AUTHORS >Jurzak M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ae2">
      <bp:ID >12738761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transactivation of the epidermal growth factor receptor mediates parathyroid hormone and prostaglandin F2 alpha-stimulated mitogen-activated protein kinase activation in cultured transgenic murine osteoblasts.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Ahmed I</bp:AUTHORS>
      <bp:AUTHORS >Gesty-Palmer D</bp:AUTHORS>
      <bp:AUTHORS >Drezner MK</bp:AUTHORS>
      <bp:AUTHORS >Luttrell LM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b38">
      <bp:ID >11812784</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transient protein-protein interactions and a random-ordered kinetic mechanism for the phosphorylation of a transcription factor by extracellular-regulated protein kinase 2.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Waas WF</bp:AUTHORS>
      <bp:AUTHORS >Dalby KN</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="da0">
      <bp:ID >9130707</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Convergence of MAP kinase pathways on the ternary complex factor Sap-1a.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Janknecht R</bp:AUTHORS>
      <bp:AUTHORS >Hunter T</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e43">
      <bp:ID >10477597</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >TNF-mediated activation of the stress-activated protein kinase pathway: TNF receptor-associated factor 2 recruits and activates germinal center kinase related.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Shi CS</bp:AUTHORS>
      <bp:AUTHORS >Leonardi A</bp:AUTHORS>
      <bp:AUTHORS >Kyriakis J</bp:AUTHORS>
      <bp:AUTHORS >Siebenlist U</bp:AUTHORS>
      <bp:AUTHORS >Kehrl JH</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c25">
      <bp:ID >10217295</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Morrison PF</bp:AUTHORS>
      <bp:AUTHORS >Morishige GM</bp:AUTHORS>
      <bp:AUTHORS >Beagles KE</bp:AUTHORS>
      <bp:AUTHORS >Heyes MP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d5b">
      <bp:ID >8713997</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Parturition: activation of stimulatory pathways or loss of uterine quiescence?</bp:TITLE>
      <bp:SOURCE >Adv Exp Med Biol</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >L&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;pez Bernal A</bp:AUTHORS>
      <bp:AUTHORS >Rivera J</bp:AUTHORS>
      <bp:AUTHORS >Europe-Finner GN</bp:AUTHORS>
      <bp:AUTHORS >Phaneuf S</bp:AUTHORS>
      <bp:AUTHORS >Asb&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;th G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c2f">
      <bp:ID >12060777</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Direct biochemical evidence for type III secretion-dependent translocation of the AvrBs2 effector protein into plant cells.</bp:TITLE>
      <bp:SOURCE >Proc Natl Acad Sci U S A</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Casper-Lindley C</bp:AUTHORS>
      <bp:AUTHORS >Dahlbeck D</bp:AUTHORS>
      <bp:AUTHORS >Clark ET</bp:AUTHORS>
      <bp:AUTHORS >Staskawicz BJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:openControlledVocabulary xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#">
      <bp:TERM xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >neuron</bp:TERM>
      <bp:ID xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >CL:0000540</bp:ID>
      <bp:Ontology xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" >Cell Type</bp:Ontology>
    </bp:openControlledVocabulary>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f98">
      <bp:ID >9733801</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Denouel-Galy A</bp:AUTHORS>
      <bp:AUTHORS >Laugier D</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Eych&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;ne A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6b">
      <bp:ID >10951185</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transcription-dependent neuronal plasticity the nuclear calcium hypothesis.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Bading H</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b5e">
      <bp:ID >9139689</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of transcription factor NF-kappaB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Wesselborg S</bp:AUTHORS>
      <bp:AUTHORS >Bauer MK</bp:AUTHORS>
      <bp:AUTHORS >Vogt M</bp:AUTHORS>
      <bp:AUTHORS >Schmitz ML</bp:AUTHORS>
      <bp:AUTHORS >Schulze-Osthoff K</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bef">
      <bp:ID >11751459</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.</bp:TITLE>
      <bp:SOURCE >Cell Growth Differ</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Wall NR</bp:AUTHORS>
      <bp:AUTHORS >Mohammad RM</bp:AUTHORS>
      <bp:AUTHORS >Al-Katib AM</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="db9">
      <bp:ID >12218141</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Complement-induced impairment of innate immunity during sepsis.</bp:TITLE>
      <bp:SOURCE >J Immunol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Huber-Lang MS</bp:AUTHORS>
      <bp:AUTHORS >Younkin EM</bp:AUTHORS>
      <bp:AUTHORS >Sarma JV</bp:AUTHORS>
      <bp:AUTHORS >McGuire SR</bp:AUTHORS>
      <bp:AUTHORS >Lu KT</bp:AUTHORS>
      <bp:AUTHORS >Guo RF</bp:AUTHORS>
      <bp:AUTHORS >Padgaonkar VA</bp:AUTHORS>
      <bp:AUTHORS >Curnutte JT</bp:AUTHORS>
      <bp:AUTHORS >Erickson R</bp:AUTHORS>
      <bp:AUTHORS >Ward PA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca5">
      <bp:ID >12414794</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ATF1 phosphorylation by the ERK MAPK pathway is required for epidermal growth factor-induced c-jun expression.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Gupta P</bp:AUTHORS>
      <bp:AUTHORS >Prywes R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ca7">
      <bp:ID >12351703</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dopamine-D2S receptor inhibition of calcium influx, adenylyl cyclase, and mitogen-activated protein kinase in pituitary cells: distinct Galpha and Gbetagamma requirements.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Banihashemi B</bp:AUTHORS>
      <bp:AUTHORS >Albert PR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f28">
      <bp:ID >12554779</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Egr-1 induction in rat granulosa cells by follicle-stimulating hormone and luteinizing hormone: combinatorial regulation by transcription factors cyclic adenosine 3',5'-monophosphate regulatory element binding protein, serum response factor, sp1,and early growth response factor-1.</bp:TITLE>
      <bp:SOURCE >Mol Endocrinol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Russell DL</bp:AUTHORS>
      <bp:AUTHORS >Doyle KM</bp:AUTHORS>
      <bp:AUTHORS >Gonzales-Robayna I</bp:AUTHORS>
      <bp:AUTHORS >Pipaon C</bp:AUTHORS>
      <bp:AUTHORS >Richards JS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fa9">
      <bp:ID >15153095</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Oxidative neuronal injury. The dark side of ERK1/2.</bp:TITLE>
      <bp:SOURCE >Eur J Biochem</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Chu CT</bp:AUTHORS>
      <bp:AUTHORS >Levinthal DJ</bp:AUTHORS>
      <bp:AUTHORS >Kulich SM</bp:AUTHORS>
      <bp:AUTHORS >Chalovich EM</bp:AUTHORS>
      <bp:AUTHORS >DeFranco DB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="a22">
      <bp:ID >11123233</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Role of p38 MAP kinase in endothelial cell alignment induced by fluid shear stress.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Heart Circ Physiol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Azuma N</bp:AUTHORS>
      <bp:AUTHORS >Akasaka N</bp:AUTHORS>
      <bp:AUTHORS >Kito H</bp:AUTHORS>
      <bp:AUTHORS >Ikeda M</bp:AUTHORS>
      <bp:AUTHORS >Gahtan V</bp:AUTHORS>
      <bp:AUTHORS >Sasajima T</bp:AUTHORS>
      <bp:AUTHORS >Sumpio BE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e4b">
      <bp:ID >12832465</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mek2 is dispensable for mouse growth and development.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >B&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;langer LF</bp:AUTHORS>
      <bp:AUTHORS >Roy S</bp:AUTHORS>
      <bp:AUTHORS >Tremblay M</bp:AUTHORS>
      <bp:AUTHORS >Brott B</bp:AUTHORS>
      <bp:AUTHORS >Steff AM</bp:AUTHORS>
      <bp:AUTHORS >Mourad W</bp:AUTHORS>
      <bp:AUTHORS >Hugo P</bp:AUTHORS>
      <bp:AUTHORS >Erikson R</bp:AUTHORS>
      <bp:AUTHORS >Charron J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d83">
      <bp:ID >9039124</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells.</bp:TITLE>
      <bp:SOURCE >Hypertension</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Graf K</bp:AUTHORS>
      <bp:AUTHORS >Xi XP</bp:AUTHORS>
      <bp:AUTHORS >Yang D</bp:AUTHORS>
      <bp:AUTHORS >Fleck E</bp:AUTHORS>
      <bp:AUTHORS >Hsueh WA</bp:AUTHORS>
      <bp:AUTHORS >Law RE</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ac0">
      <bp:ID >12600988</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Independent and cooperative activation of chromosomal c-fos promoter by STAT3.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Yang E</bp:AUTHORS>
      <bp:AUTHORS >Lerner L</bp:AUTHORS>
      <bp:AUTHORS >Besser D</bp:AUTHORS>
      <bp:AUTHORS >Darnell JE Jr</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e44">
      <bp:ID >11238126</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Morgan MA</bp:AUTHORS>
      <bp:AUTHORS >Dolp O</bp:AUTHORS>
      <bp:AUTHORS >Reuter CW</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d6c">
      <bp:ID >12225966</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Duality of G protein-coupled mechanisms for beta-adrenergic activation of NKCC activity in skeletal muscle.</bp:TITLE>
      <bp:SOURCE >Am J Physiol Cell Physiol</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Gosmanov AR</bp:AUTHORS>
      <bp:AUTHORS >Wong JA</bp:AUTHORS>
      <bp:AUTHORS >Thomason DB</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ab5">
      <bp:ID >10542136</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Cholera toxin induces tumor necrosis factor alpha production in human monocytes.</bp:TITLE>
      <bp:SOURCE >Mol Cell Biol Res Commun</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Yan Z</bp:AUTHORS>
      <bp:AUTHORS >Yang DC</bp:AUTHORS>
      <bp:AUTHORS >Jett M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f8b">
      <bp:ID >14724213</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Developmental regulation of the 5-HT7 serotonin receptor and transcription factor NGFI-A in the fetal guinea-pig limbic system: influence of GCs.</bp:TITLE>
      <bp:SOURCE >J Physiol</bp:SOURCE>
      <bp:YEAR >2004</bp:YEAR>
      <bp:AUTHORS >Andrews MH</bp:AUTHORS>
      <bp:AUTHORS >Kostaki A</bp:AUTHORS>
      <bp:AUTHORS >Setiawan E</bp:AUTHORS>
      <bp:AUTHORS >McCabe L</bp:AUTHORS>
      <bp:AUTHORS >Owen D</bp:AUTHORS>
      <bp:AUTHORS >Banjanin S</bp:AUTHORS>
      <bp:AUTHORS >Matthews SG</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bfc">
      <bp:ID >16189297</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Activation of adenylyl cyclase by endogenous G(s)-coupled receptors in human embryonic kidney 293 cells is attenuated by 5-HT(7) receptor expression.</bp:TITLE>
      <bp:SOURCE >Mol Pharmacol</bp:SOURCE>
      <bp:YEAR >2006</bp:YEAR>
      <bp:AUTHORS >Andressen KW</bp:AUTHORS>
      <bp:AUTHORS >Norum JH</bp:AUTHORS>
      <bp:AUTHORS >Levy FO</bp:AUTHORS>
      <bp:AUTHORS >Krobert KA</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="de0">
      <bp:ID >12808055</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Regulation of PRAK subcellular location by p38 MAP kinases.</bp:TITLE>
      <bp:SOURCE >Mol Biol Cell</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >New L</bp:AUTHORS>
      <bp:AUTHORS >Jiang Y</bp:AUTHORS>
      <bp:AUTHORS >Han J</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bf8">
      <bp:ID >9724043</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Prostaglandin F2alpha stimulates the Raf/MEK1/mitogen-activated protein kinase signaling cascade in bovine luteal cells.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >1998</bp:YEAR>
      <bp:AUTHORS >Chen DB</bp:AUTHORS>
      <bp:AUTHORS >Westfall SD</bp:AUTHORS>
      <bp:AUTHORS >Fong HW</bp:AUTHORS>
      <bp:AUTHORS >Roberson MS</bp:AUTHORS>
      <bp:AUTHORS >Davis JS</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b31">
      <bp:ID >12393899</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >ERK1/2 antagonizes glycogen synthase kinase-3beta-induced apoptosis in cortical neurons.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Hetman M</bp:AUTHORS>
      <bp:AUTHORS >Hsuan SL</bp:AUTHORS>
      <bp:AUTHORS >Habas A</bp:AUTHORS>
      <bp:AUTHORS >Higgins MJ</bp:AUTHORS>
      <bp:AUTHORS >Xia Z</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d25">
      <bp:ID >11259513</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats.</bp:TITLE>
      <bp:SOURCE >J Neurochem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Millan MJ</bp:AUTHORS>
      <bp:AUTHORS >Lejeune F</bp:AUTHORS>
      <bp:AUTHORS >De Nanteuil G</bp:AUTHORS>
      <bp:AUTHORS >Gobert A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e2c">
      <bp:ID >10391889</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Rolli M</bp:AUTHORS>
      <bp:AUTHORS >Kotlyarov A</bp:AUTHORS>
      <bp:AUTHORS >Sakamoto KM</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
      <bp:AUTHORS >Neininger A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="aa8">
      <bp:ID >11846562</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Crystal structure of a ternary SAP-1/SRF/c-fos SRE DNA complex.</bp:TITLE>
      <bp:SOURCE >J Mol Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Mo Y</bp:AUTHORS>
      <bp:AUTHORS >Ho W</bp:AUTHORS>
      <bp:AUTHORS >Johnston K</bp:AUTHORS>
      <bp:AUTHORS >Marmorstein R</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="c16">
      <bp:ID >10781004</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of the adenylyl cyclase-activating 5-hydroxytryptamine receptor subtypes expressed in the rat submandibular gland.</bp:TITLE>
      <bp:SOURCE >Br J Pharmacol</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Bourdon DM</bp:AUTHORS>
      <bp:AUTHORS >Camden JM</bp:AUTHORS>
      <bp:AUTHORS >Landon LA</bp:AUTHORS>
      <bp:AUTHORS >Levy FO</bp:AUTHORS>
      <bp:AUTHORS >Turner JT</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f0c">
      <bp:ID >11278709</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Basic fibroblast growth factor-induced activation of novel CREB kinase during the differentiation of immortalized hippocampal cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Sung JY</bp:AUTHORS>
      <bp:AUTHORS >Shin SW</bp:AUTHORS>
      <bp:AUTHORS >Ahn YS</bp:AUTHORS>
      <bp:AUTHORS >Chung KC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="b12">
      <bp:ID >12628924</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Vermeulen L</bp:AUTHORS>
      <bp:AUTHORS >De Wilde G</bp:AUTHORS>
      <bp:AUTHORS >Van Damme P</bp:AUTHORS>
      <bp:AUTHORS >Vanden Berghe W</bp:AUTHORS>
      <bp:AUTHORS >Haegeman G</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bcf">
      <bp:ID >11701463</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells.</bp:TITLE>
      <bp:SOURCE >Arterioscler Thromb Vasc Biol</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Tokunou T</bp:AUTHORS>
      <bp:AUTHORS >Ichiki T</bp:AUTHORS>
      <bp:AUTHORS >Takeda K</bp:AUTHORS>
      <bp:AUTHORS >Funakoshi Y</bp:AUTHORS>
      <bp:AUTHORS >Iino N</bp:AUTHORS>
      <bp:AUTHORS >Takeshita A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="acf">
      <bp:ID >9057106</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Conformation-dependent activation of type II adenylyl cyclase by protein kinase C.</bp:TITLE>
      <bp:SOURCE >J Cell Biochem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Ebina T</bp:AUTHORS>
      <bp:AUTHORS >Kawabe J</bp:AUTHORS>
      <bp:AUTHORS >Katada T</bp:AUTHORS>
      <bp:AUTHORS >Ohno S</bp:AUTHORS>
      <bp:AUTHORS >Homcy CJ</bp:AUTHORS>
      <bp:AUTHORS >Ishikawa Y</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="fc4">
      <bp:ID >11520792</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression.</bp:TITLE>
      <bp:SOURCE >Blood</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Guha M</bp:AUTHORS>
      <bp:AUTHORS >O'Connell MA</bp:AUTHORS>
      <bp:AUTHORS >Pawlinski R</bp:AUTHORS>
      <bp:AUTHORS >Hollis A</bp:AUTHORS>
      <bp:AUTHORS >McGovern P</bp:AUTHORS>
      <bp:AUTHORS >Yan SF</bp:AUTHORS>
      <bp:AUTHORS >Stern D</bp:AUTHORS>
      <bp:AUTHORS >Mackman N</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cbf">
      <bp:ID >11839761</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The activity of the extracellular signal-regulated kinase 2 is regulated by differential phosphorylation in the activation loop.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2002</bp:YEAR>
      <bp:AUTHORS >Zhou B</bp:AUTHORS>
      <bp:AUTHORS >Zhang ZY</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d7a">
      <bp:ID >10650934</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Insulin-like growth factor I activates c-Jun N-terminal kinase in MCF-7 breast cancer cells.</bp:TITLE>
      <bp:SOURCE >Endocrinology</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Monno S</bp:AUTHORS>
      <bp:AUTHORS >Newman MV</bp:AUTHORS>
      <bp:AUTHORS >Cook M</bp:AUTHORS>
      <bp:AUTHORS >Lowe WL Jr</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="ef1">
      <bp:ID >9316442</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Dexamethasone increases G alpha q-11 expression and hormone-stimulated phospholipase C activity in UMR-106-01 cells.</bp:TITLE>
      <bp:SOURCE >Am J Physiol</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Mitchell J</bp:AUTHORS>
      <bp:AUTHORS >Bansal A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="bd4">
      <bp:ID >11006268</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Thyroid-stimulating hormone and cyclic AMP activate p38 mitogen-activated protein kinase cascade. Involvement of protein kinase A, rac1, and reactive oxygen species.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Pomerance M</bp:AUTHORS>
      <bp:AUTHORS >Abdullah HB</bp:AUTHORS>
      <bp:AUTHORS >Kamerji S</bp:AUTHORS>
      <bp:AUTHORS >Correze C</bp:AUTHORS>
      <bp:AUTHORS >Blondeau JP</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d1b">
      <bp:ID >1683468</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >A pyruvate-stimulated adenylate cyclase has a sequence related to the fes/fps oncogenes and to eukaryotic cyclases.</bp:TITLE>
      <bp:SOURCE >Mol Microbiol</bp:SOURCE>
      <bp:YEAR >1991</bp:YEAR>
      <bp:AUTHORS >Peters EP</bp:AUTHORS>
      <bp:AUTHORS >Wilderspin AF</bp:AUTHORS>
      <bp:AUTHORS >Wood SP</bp:AUTHORS>
      <bp:AUTHORS >Zvelebil MJ</bp:AUTHORS>
      <bp:AUTHORS >Sezer O</bp:AUTHORS>
      <bp:AUTHORS >Danchin A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e9a">
      <bp:ID >9395450</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1997</bp:YEAR>
      <bp:AUTHORS >Traub O</bp:AUTHORS>
      <bp:AUTHORS >Monia BP</bp:AUTHORS>
      <bp:AUTHORS >Dean NM</bp:AUTHORS>
      <bp:AUTHORS >Berk BC</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="caa">
      <bp:ID >7592979</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Engel K</bp:AUTHORS>
      <bp:AUTHORS >Schultz H</bp:AUTHORS>
      <bp:AUTHORS >Martin F</bp:AUTHORS>
      <bp:AUTHORS >Kotlyarov A</bp:AUTHORS>
      <bp:AUTHORS >Plath K</bp:AUTHORS>
      <bp:AUTHORS >Hahn M</bp:AUTHORS>
      <bp:AUTHORS >Heinemann U</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="cf5">
      <bp:ID >8846784</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Ben-Levy R</bp:AUTHORS>
      <bp:AUTHORS >Leighton IA</bp:AUTHORS>
      <bp:AUTHORS >Doza YN</bp:AUTHORS>
      <bp:AUTHORS >Attwood P</bp:AUTHORS>
      <bp:AUTHORS >Morrice N</bp:AUTHORS>
      <bp:AUTHORS >Marshall CJ</bp:AUTHORS>
      <bp:AUTHORS >Cohen P</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="dda">
      <bp:ID >7731720</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >B-Raf protein isoforms interact with and phosphorylate Mek-1 on serine residues 218 and 222.</bp:TITLE>
      <bp:SOURCE >Oncogene</bp:SOURCE>
      <bp:YEAR >1995</bp:YEAR>
      <bp:AUTHORS >Papin C</bp:AUTHORS>
      <bp:AUTHORS >Eych&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;ne A</bp:AUTHORS>
      <bp:AUTHORS >Brunet A</bp:AUTHORS>
      <bp:AUTHORS >Pag&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;s G</bp:AUTHORS>
      <bp:AUTHORS >Pouyss&#195;&#131;&#194;&#175;&#195;&#130;&#194;&#191;&#195;&#130;&#194;&#189;gur J</bp:AUTHORS>
      <bp:AUTHORS >Calothy G</bp:AUTHORS>
      <bp:AUTHORS >Barnier JV</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="f34">
      <bp:ID >11406578</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >The B-box dominates SAP-1-SRF interactions in the structure of the ternary complex.</bp:TITLE>
      <bp:SOURCE >EMBO J</bp:SOURCE>
      <bp:YEAR >2001</bp:YEAR>
      <bp:AUTHORS >Hassler M</bp:AUTHORS>
      <bp:AUTHORS >Richmond TJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="e7c">
      <bp:ID >16303171</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat.</bp:TITLE>
      <bp:SOURCE >Front Neuroendocrinol</bp:SOURCE>
      <bp:YEAR >2005</bp:YEAR>
      <bp:AUTHORS >Szyf M</bp:AUTHORS>
      <bp:AUTHORS >Weaver IC</bp:AUTHORS>
      <bp:AUTHORS >Champagne FA</bp:AUTHORS>
      <bp:AUTHORS >Diorio J</bp:AUTHORS>
      <bp:AUTHORS >Meaney MJ</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d63">
      <bp:ID >10318869</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >MAPKAP kinase 2 phosphorylates serum response factor in vitro and in vivo.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >1999</bp:YEAR>
      <bp:AUTHORS >Heidenreich O</bp:AUTHORS>
      <bp:AUTHORS >Neininger A</bp:AUTHORS>
      <bp:AUTHORS >Schratt G</bp:AUTHORS>
      <bp:AUTHORS >Zinck R</bp:AUTHORS>
      <bp:AUTHORS >Cahill MA</bp:AUTHORS>
      <bp:AUTHORS >Engel K</bp:AUTHORS>
      <bp:AUTHORS >Kotlyarov A</bp:AUTHORS>
      <bp:AUTHORS >Kraft R</bp:AUTHORS>
      <bp:AUTHORS >Kostka S</bp:AUTHORS>
      <bp:AUTHORS >Gaestel M</bp:AUTHORS>
      <bp:AUTHORS >Nordheim A</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="d17">
      <bp:ID >10625698</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Effect of contraction on mitogen-activated protein kinase signal transduction in skeletal muscle. Involvement Of the mitogen- and stress-activated protein kinase 1.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2000</bp:YEAR>
      <bp:AUTHORS >Ryder JW</bp:AUTHORS>
      <bp:AUTHORS >Fahlman R</bp:AUTHORS>
      <bp:AUTHORS >Wallberg-Henriksson H</bp:AUTHORS>
      <bp:AUTHORS >Alessi DR</bp:AUTHORS>
      <bp:AUTHORS >Krook A</bp:AUTHORS>
      <bp:AUTHORS >Zierath JR</bp:AUTHORS>
    </bp:PublicationXref>
    <bp:PublicationXref xmlns:bp="http://www.biopax.org/release/biopax-level3.owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" rdf:id="faa">
      <bp:ID >12855697</bp:ID>
      <bp:DB >PubMed</bp:DB>
      <bp:TITLE >Ectopic B-Raf expression enhances extracellular signal-regulated kinase (ERK) signaling in T cells and prevents antigen-presenting cell-induced anergy.</bp:TITLE>
      <bp:SOURCE >J Biol Chem</bp:SOURCE>
      <bp:YEAR >2003</bp:YEAR>
      <bp:AUTHORS >Dillon TJ</bp:AUTHORS>
      <bp:AUTHORS >Karpitski V</bp:AUTHORS>
      <bp:AUTHORS >Wetzel SA</bp:AUTHORS>
      <bp:AUTHORS >Parker DC</bp:AUTHORS>
      <bp:AUTHORS >Shaw AS</bp:AUTHORS>
      <bp:AUTHORS >Stork PJ</bp:AUTHORS>
    </bp:PublicationXref>
  </Biopax>
</Pathway>